Allergy Therapeutics PLC has received a notification of major holdings from ZQ Capital Management Limited, Sky Gem Acquisition Limited, ZQ Capital Limited, and SHEN Zheqing. The notification states that the total positions of these entities amount to 60.310% of voting rights attached to shares, with 59.959% held directly and 0.351% held through financial instruments. The total number of voting rights held in the company is 2,866,963,142. This represents an increase from the previous notification, which indicated a position of 25.580% of voting rights. The notification also provides details of the financial instruments held, including warrants that may be exercised in the future. The notification was completed in Hong Kong on October 16, 2023.